ENDRA Life Sciences Inc. (NASDAQ:NDRA) IPO
IPO
Declared effective by the SEC on Feb 12, 2019. Filed with the SEC to go public on Nov 21, 2016.
- Price range
- US$5.00 to US$5.50 a unit
- Units offered
- 1,400,000 units
- Offering size
- US$7 million to US$7.7 million · Units offered times the price range, worked out by 6ix
- Underwriters' option
- Up to 210,000 more units
- Listing
- NDRAU on the Nasdaq Capital Market
- Underwriters
- National Securities Corporation, Dougherty & Company · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Aug 9, 2016 |
| Filed publicly | Nov 21, 2016 |
| Amended 13 times | Newest Jan 24, 2019 |
| Shares registered with an exchange | Dec 16, 2016 |
| Declared effective by the SEC | Feb 12, 2019 |
| Final prospectus, with the price | Not yet |
Filings
From the cover of the amended prospectus (S-1/A) filed May 1, 2017